尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
INVESTORS SERVICE
Announcement Notice of Board Meeting
2023-03-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 2
2023-03-02
Overseas Regulatory Announcement-Announcement on Sevelamer Carbonate Tablets Obt
2023-02-27
Overseas Regulatory Announcement
2023-02-17
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-02-01
Next Day Disclosure Return
2023-01-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-01-03
Grant of Reserved Share Options Under the Share Option Scheme
2022-12-23
Unusual Price and Trading Volume Movements
2022-12-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2022-12-01
<
...
11
12
13
14
15
16
17
...
>